SCHEMBL4807384

SCHEMBL4807384

Ic1ccc(NN=Cc2ccccn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.56
MAPT P10636 7/20 0.56
RAB9A P51151 6/20 0.56
GAA P10253 6/20 0.56
TDP1 Q9NUW8 6/20 0.56
SMN1; SMN2 Q16637 6/20 0.56
LMNA P02545 5/20 0.56
POLB P06746 3/20 0.56
ALDH1A1 P00352 2/20 0.56
PAX8 Q06710 2/20 0.51
HTT P42858 6/20 0.49
NPC1 O15118 5/20 0.49
KMT2A Q03164 5/20 0.49
NPSR1 Q6W5P4 4/20 0.49
PKM P14618 4/20 0.49
L3MBTL1 Q9Y468 4/20 0.48
MEN1 O00255 2/20 0.47
MITF O75030 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4807377 1.00 KDM4E (0.56) KDM4EMAPTRAB9AGAATDP1
SCHEMBL3079735 0.86 KDM4E (0.58) KDM4EMAPTRAB9AGAATDP1
SCHEMBL6711432 0.86 KDM4E (0.58) KDM4EMAPTRAB9AGAATDP1
SCHEMBL6493566 0.84 RAB9A (0.59) KDM4EMAPTRAB9AGAATDP1
SCHEMBL6501236 0.84 RAB9A (0.60) KDM4EMAPTRAB9AGAATDP1
SCHEMBL28170008 0.81 PAX8 (0.58) KDM4EMAPTRAB9AGAATDP1
SCHEMBL6504390 0.80 CTH (0.57) KDM4EMAPTRAB9AGAATDP1
SCHEMBL12858541 0.79 RAB9A (0.69) KDM4EMAPTRAB9AGAATDP1
SCHEMBL3146064 0.78 MEN1 (0.65) KDM4EMAPTRAB9AGAATDP1
SCHEMBL3146074 0.78 MEN1 (0.65) KDM4EMAPTRAB9AGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PFIZER INC 2008-04-17 US disclosed
WO-2008004117-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PFIZER PRODUCTS INC. (US) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PDE5A, PDE3B, PDE12 KDM4E 636/4885MAPT 964/4885RAB9A 870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.